New injection aims to heal painful achilles tendons

NCT ID NCT05592990

Completed Disease control Sponsor: Novartis Pharmaceuticals Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a single injection of tiny particles (NGI226) to see if it safely helps repair damaged Achilles tendons. 45 adults with mid-portion Achilles tendinopathy received either the study drug or a placebo. Researchers measured side effects and changes in tendon stiffness using ultrasound over 12 weeks.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACHILLES TENDINOPATHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACHILLES TENDINOPATHY

Contacts and locations

Locations

Advanced Research LLC

Deerfield Beach, Florida, 33064, United States
Houston Methodist Hospital

Houston, Texas, 77030, United States
Novartis Investigative Site

Caluire-et-Cuire, 69300, France
Novartis Investigative Site

Berlin, 10117, Germany
Novartis Investigative Site

Hamburg, 20149, Germany
Novartis Investigative Site

Hamburg, 22415, Germany
Tucson Orthopedic Institute PC

Tucson, Arizona, 85712, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.